Red cell distribution width predicts short- and long-term outcomes of acute congestive heart failure more effectively than hemoglobin

Experimental and Therapeutic Medicine

Volumn 8, Issue 2, 2014, Pages 600-606

  Dai, Yuxiang ^a,b   Konishi, Hakuoh ^a   Takagi, Atsutoshi ^a   Miyauchi, Katsumi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUDAN UNIVERSITY   (China)

Author keywords

Anemia; Biomarker; Heart failure; Prognosis; Red blood cell distribution width

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART FAILURE; ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CELLULAR DISTRIBUTION; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; ERYTHROCYTE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERVIEW; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RED BLOOD CELL DISTRIBUTION WIDTH; TELEPHONE; UREA NITROGEN BLOOD LEVEL;

EID: 84902580176     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1755     Document Type: Article

References (34)

1. Levy D, Kenchaiah S, Larson MG, et al: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402, 2002
2. Mueller C, Laule-Kilian K, Christ A, et al: Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 151: 845-850, 2006.
3. Roger VL, Weston SA, Redfield MM, et al: Trends in heart failure incidence and survival in a community-based population. JAMA 292: 344-350, 2004.
4. Cowie MR, Wood DA, Coats AJ, et al: Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83: 505-510, 2000.
5. Xue Y, Chan J, Sakariya S, and Maisel A: Biomarker-guided treatment of congestive heart failure. Congest Heart Fail 16 (Suppl 1): S62-S67, 2010.
6. Allen LA: Use of multiple biomarkers in heart failure. Curr Cardiol Rep 12: 230-236, 2010.
7. Vistnes M, Christensen G and Omland T: Multiple cytokine biomarkers in heart failure. Expert Rev Mol Diagn 10: 147-157, 2010.
8. Bozkurt B, Mann DL and Deswal A: Biomarkers of inflammation in heart failure. Heart Fail Rev 15: 331-341, 2010.
9. Araújo JP, Lourenço P, Azevedo A, et al: Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 15: 256-266, 2009.
10. Rehman SU and Januzzi JL Jr: Natriuretic peptides for guiding heart failure therapy. Compr Ther 34: 32-40, 2008.
11. Adams KF Jr, Felker GM, Fraij G, et al: Biomarker guided therapy for heart failure: focus on natriuretic peptides. Heart Fail Rev 15: 351-370, 2010.
12. Odedra K and Ferro A: Neurohormones and heart failure: the importance of aldosterone. Int J Clin Pract 60: 835-846, 2006.
13. Trachtenberg BH and Hare JM: Biomarkers of oxidative stress in heart failure. Heart Fail Clin 5: 561-577, 2009.
14. Belziti CA: Prevalence of anemia in heart failure and its effects on prognosis. Expert Rev Cardiovasc Ther 7: 131-138, 2009.
15. Salisbury AC and Kosiborod M: Outcomes associated with anemia in patients with heart failure. Heart Fail Clin 6: 359-372, 2010.
16. He SW and Wang LX: The impact of anemia on the prognosis of chronic heart failure: a meta-analysis and systemic review. Congest Heart Fail 15: 123-130, 2009.
17. Ghali JK: Anemia and heart failure. Curr Opin Cardiol 24: 172-178, 2009.
18. Dabbah S, Hammerman H, Markiewicz W and Aronson D: Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol 105: 312-317, 2010.
19. Nabais S, Losa N, Gaspar A, et al: Association between red blood cell distribution width and outcomes at six months in patients with acute coronary syndromes. Rev Port Cardiol 28: 905-924, 2009.
20. Förhécz Z, Gombos T, Borgulya G, et al: Red cell distribution width: a powerful prognostic marker in heart failure. Eur J Heart Fail 12: 415, 2010.
21. Al-Najjar Y, Goode KM, Zhang J, et al: Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail 11: 1155-1162, 2009.
22. van Kimmenade RR, Mohammed AA, Uthamalingam S, et al: Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 12: 129-136, 2010.
23. Pascual-Figal DA, Bonaque JC, Redondo B, Caro C, Manzano-Fernandez S, Sánchez-Mas J, Garrido IP and Valdes M: Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail 11: 840-846, 2009.
24. Evans TC and Jehle D: The red blood cell distribution width. J Emerg Med 9: 71-74, 1991.
25. Viswanath D, Hegde R, Murthy V, et al: Red cell distribution width in the diagnosis of iron deficiency anemia. Indian J Pediatr 68: 1117-1119, 2001.
26. Crosato M, Steinborn W and Anker SD: Anemia in chronic congestive heart failure: frequency, prognosis, and treatment. Heart Fail Monit 4: 2-6, 2003.
27. Terrovitis JV, Anastasiou-Nana M, Kaldara E, et al: Anemia in heart failure: pathophysiologic insights and treatment options. Future Cardiol 5: 71-81, 2009.
28. Felker GM, Adams KF Jr, Gattis WA and O'Connor CM: Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44: 959-966, 2004.
29. Pierce CN and Larson DF: Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 20: 83-90, 2005.
30. Felker GM, Allen LA, Pocock SJ, et al; CHARM Investigators: Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50: 40-47, 2007.
31. Maisel A: B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation 105: 2328-2331, 2002.
32. Ikonomidis I, Michalakeas CA, Lekakis J, et al: Multimarker approach in cardiovascular risk prediction. Dis Markers 26: 273-285, 2009.
33. Velagaleti RS, Gona P, Larson MG, et al: Multimarker approach for the prediction of heart failure incidence in the community. Circulation 122: 1700-1706, 2010.
34. Yin WH, Chen JW, Feng AN, et al: Multimarker approach to risk stratification among patients with advanced chronic heart failure. Clin Cardiol 30: 397-402, 2007.